CDC Delays Publishing Report Showing Covid Vaccine Benefits
The acting director of the CDC has postponed a report that found COVID‑19 vaccines cut emergency‑department visits and hospitalizations for healthy adults by roughly 50% last winter. Officials say the delay stems from concerns about the study’s methodology, a design traditionally used to assess vaccine effectiveness. Critics argue the hold‑up reflects political pressure from Health Secretary Robert F. Kennedy Jr., a vocal vaccine skeptic. The report, originally slated for March 19 in the Morbidity and Mortality Weekly Report, remains unpublished.
Ossium Health Hosts Facility Tour and Reception for Indiana Governor Mike Braun and Healthcare Leaders
Ossium Health hosted a facility tour and reception with Indiana Governor Mike Braun, showcasing its 34,000‑square‑foot Indianapolis plant that houses five ISO 7 cleanrooms and a bone‑marrow banking platform. The company has treated 23 patients using organ donor‑derived bone marrow, underscoring...
New Billboards Tout AHF as Top HIV Provider, Promote STD Testing
AIDS Healthcare Foundation (AHF) launched two national outdoor campaigns, branding itself as “America’s #1 HIV Provider” and promoting free STD testing through the “Peace of Mind” theme. The first campaign highlights AHF’s care for over 234,000 patients across 19 states,...
Vedanta Biosciences Showcases Innovative Work on Its Microbiome-Based Therapeutics at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)...
Vedanta Biosciences presented a poster on its eight‑strain consortium VE303 and an oral talk on VE707 at the ESCMID 2026 Congress in Munich. VE303 showed more than an 80% reduction in recurrent Clostridioides difficile infection odds in a Phase 2 trial...
Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association
Charles River Laboratories announced a partnership with the American Heart Association to back its Heart of Boston campaign, targeting cardiovascular disease awareness and prevention. The collaboration aligns with Charles River’s corporate purpose of creating healthier lives and its broader citizenship...
TriSalus Life Sciences to Present New Data at the 2026 Society of Interventional Radiology Annual Scientific Meeting
TriSalus Life Sciences will present new pre‑clinical and clinical data on its Pressure Enabled Drug Delivery™ (PEDD) platform at the Society of Interventional Radiology 2026 Annual Scientific Meeting in Toronto. The company’s posters and sessions will cover hepatic tumor penetration...
MDRXLaw Launches MDRXResolve: A Smart, Efficient Alternative to Litigation for Healthcare Disputes
MDRXLaw introduced MDRXResolve, a mediation platform tailored for healthcare providers, offering a discreet, efficient alternative to litigation. The service addresses partnership, contractual, regulatory, and employee disputes, aiming to cut costs, reduce delays, and protect operational continuity. Leveraging MDRXLaw’s experience, the...
Thursday Discussion Post
Johns Hopkins Clinical and Translational Research Institute announced a clinical trial for a combined Shigella and ETEC vaccine aimed at preventing traveler’s diarrhea. The study will enroll volunteers for outpatient and inpatient arms, offering compensation of up to $5,100. The...
Bispecific ADCs and the Conditions Nobody Is Talking About
Sidewinder Therapeutics announced a $137 million Series B round to push precision bispecific antibody‑drug conjugates (BspADCs) into clinical trials. The funding follows a prior preview of the emerging bispecific ADC niche at AACR, highlighting a surge of early‑stage programs. While the concept...
7th and Possibly Final Update on the $39.94 Lab Test Bill
In May 2025 the author received a $34.95 bill from LabCorp for a lab test that should have been covered as a preventive service under the ACA. The initial claim was mis‑coded by One Medical, prompting a $39.94 charge after...
Baebies’ Finder Platform Secures Dual FDA Clearance and CLIA Waiver
Baebies announced that its Finder platform has received FDA 510(k) clearance for a Flu A&B/SARS‑CoV‑2 test and a CLIA waiver, making it the first molecular point‑of‑care system with multifunctional capabilities. The cartridge‑based device delivers PCR‑quality results in 15‑20 minutes, enabling...
Parkinson’s Awareness Month and World Parkinson’s Day 2026: Advocacy and Therapeutic Progress
April marks Parkinson’s Awareness Month, culminating in World Parkinson’s Day on April 11, which unites patients, clinicians and advocates worldwide. The disease now affects roughly 11.8 million people and could rise to 25 million by 2050, making early recognition critical. Recent therapeutic advances...
Why, if After 7 to 21 Years of Follow-Up Data, Disc Arthroplasty Has a Mere 0.67% Index Level Revision Rate,...
A new long‑term cohort study of 1,187 lumbar total disc arthroplasty (TDA) patients tracked outcomes for 7 to 21 years, revealing a 0.67% index‑level revision rate and 1.85% adjacent‑level surgery rate. Pain scores and Oswestry Disability Index improvements appeared within...
Pharmaceutical Executive Daily: Shionogi Receives Contract Through BARDA's Project BioShield
Shionogi’s U.S. subsidiary secured a BARDA Project BioShield contract that could total $482 million to develop and manufacture its gram‑negative antibiotic Fetroja, with an initial $119 million funded. The agreement funds a U.S. production facility and expands research against high‑priority biothreat pathogens...
Why Walking Matters Most in Post-Acute Rehabilitation
Walking is the central metric families use to gauge recovery in post‑acute rehabilitation, symbolizing independence and a return home. Patients arriving after stroke, hip fracture, or severe illness often face rapid muscle loss, making gait restoration a critical therapeutic goal....
The Hidden Crisis of Trainee Health During Medical Residency
Dr. Chinyelu Oraedu recounts a 48‑hour ordeal in 2009 when she, a pregnant internal‑medicine resident, juggled an urgent cesarean delivery and the final USMLE Step 3 exam. The episode exposes how delayed lab results and inflexible residency schedules force trainees to...
World Health Day: With RFK Jr as US Health Secretary, 'Standing With' Science Isn't Enough
World Health Day this year spotlights the WHO’s "stand with science" campaign, but the slogan is under scrutiny as the United States nominates Robert F. Kennedy Jr. as health secretary. Kennedy, a known vaccine skeptic, casts doubt on the administration’s...
Thursday April 9, 2026 — Field Note
Boston Scientific’s Watchman FLX left‑atrial appendage closure device demonstrated non‑inferiority to direct oral anticoagulants (DOACs) on a composite endpoint of cardiovascular death, stroke and systemic embolism in the CHAMPION‑AF trial presented at ACC.26 and published in NEJM, and it achieved...
Landmark Federal Indictment for Pop Peptides Alleged ‘Scheme’ Even as RFK Jr. May Soon Un-Ban Some
A federal grand jury indicted Dr. Justin Watkins, owner of Utah's TruHealth Clinic, for relabeling Chinese‑manufactured peptides and selling them to more than 200 patients without disclosing the source or FDA status. The indictment alleges that the clinic repackaged the...
Health Care Lobbying Is Destroying the U.S. System
Record health‑care lobbying reached $4.5 billion in 2024, with $758 million funneled to members of key congressional health committees. A 2021 Supreme Court ruling on donor disclosure has made tracing dark‑money contributions harder, allowing pharmaceutical, insurer and hospital groups to shape policy...
Athenahealth Targets AI-Driven Patient Discovery with New Rater8 Reputation Management Integration
athenahealth has embedded rater8’s AI‑powered reputation management directly into its athenaOne EHR platform, allowing ambulatory practices to capture reviews, monitor sentiment, and manage directory listings without leaving their clinical workflow. The move is part of athenahealth’s new Alliance Partnerships program,...
Low-Dose Lithium Treats Suicidal Ideation Safely
Low‑dose lithium (150‑300 mg) rapidly eliminated suicidal thoughts in young patients, with effects observed within days and sustained over years. Decades of research show lithium uniquely reduces suicide risk, outperforming alternatives like clozapine and ketamine, while its narrow therapeutic window at...
Relacorilant (CORT125134)
Corcept Therapeutics received FDA approval for relacorilant, branded Lifyorli, in combination with nab‑paclitaxel for platinum‑resistant ovarian cancer. The oral agent is a selective glucocorticoid‑receptor antagonist that blocks cortisol signaling without binding other steroid receptors, differentiating it from older cortisol‑pathway drugs....
GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More...
GoodRx announced a partnership with Eli Lilly to offer the newly FDA‑approved oral GLP‑1 drug Foundayo (orforglipron) at a self‑pay price of $149 per month. The platform is also rolling out self‑pay pricing for Lilly’s injectable Zepbound (tirzepatide) KwikPen at $299...
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Sensei Biotherapeutics announced it will present at the 25th Annual Needham Virtual Healthcare Conference on April 16, 2026. The webcast will be streamed live at 12:45 p.m. ET with a 90‑day replay window. Executives will detail the company’s lead PIKTOR program for endometrial...
NEUPATH HEALTH TO PRESENT AT THE 2026 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE
NeuPath Health Inc. announced that CEO Stephen Lemieux will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference on April 22, 2026. The 30‑minute virtual session, streamed from the Metro Toronto Convention Centre, will include a live Q&A...
Cartography Biosciences Advances Strategic Oncology Collaboration with Gilead’s First Option Target Exercise
Cartography Biosciences announced that Gilead Sciences exercised its first option to exclusively license a novel oncology target identified through Cartography’s ATLAS and SUMMIT single‑cell platforms. The target is part of a multi‑year collaboration aimed at tumor‑selective antigens in triple‑negative breast...
Hospitals That Sue You for Getting Sick
A joint GWU‑Stanford report reveals that Virginia hospitals filed 1.15 million lawsuits from 2010 to 2024, seeking $1.4 billion in unpaid medical debt. More than 400,000 wage and bank garnishments followed, with attorneys earning $87 million in fees and courts adding $46 million in...
Psilocybin Mushrooms Are Going Mainstream, but Scientific Research and Regulation Lag Behind
Psilocybin mushroom use is exploding in the United States, with recent estimates showing about 11 million adults tried the substance in 2026. Legal reforms have decriminalized possession in cities like Denver and created supervised‑use programs in Oregon and Colorado, but most...
MediFind Becomes First Doctor Directory to Receive the Digital Medicine Society Seal
MediFind, the data‑driven online provider directory owned by Phreesia, has become the first doctor directory to earn the Digital Medicine Society (DiMe) Seal. The seal recognizes platforms that meet rigorous standards for clinical evidence, privacy, security, and usability. MediFind leverages...
I Tried Ozempic. This Is What You Need to Know.
A dietitian purchased Ozempic through an online telehealth service by simply misrepresenting her medical history, exposing how lax verification enables easy access to GLP‑1 drugs. She kept the medication in her fridge, later self‑administered a 0.25 mg dose, and reflected on...
Laura Blair: Rethinking Hub Efficiency and the Role of AI in Patient Support
ConnectiveRx’s chief commercial officer Laura Blair says specialty‑pharma patient‑support hubs are under‑utilized, with only 10‑15% of eligible patients engaging. She attributes the gap to design and access flaws rather than technology, noting that cumbersome enrollment and regulatory hurdles deter usage....
Unpacking the Healthcare Hiring Boom
The healthcare and social assistance sector added roughly 1.7 million jobs since the start of 2024, while all other industries collectively shed about 56,000 positions. Almost half of the new jobs are concentrated in nursing care facilities and services for the...
Accelerating Into Fraud
MEDVi, a two‑person telehealth startup, is projected to generate $1.8 billion in 2026 by selling compounded GLP‑1 weight‑loss drugs through the white‑labeled OpenLoop platform. The company relies heavily on AI‑generated marketing, virtual doctors, and automated customer service to drive sales. A...
How Texas Children’s Saved $14M with Zebra RFID Solutions: RFID Journal Case Study
Texas Children’s Hospital partnered with Zebra Technologies and Tecsys to install an RFID‑powered pharmacy system, replacing manual counts with real‑time tracking. The new workflow slashed medication tagging time from two minutes to seven seconds and lifted cabinet inventory accuracy to...
Why Florida Physician Background Checks Are Driving Doctors Away
Florida lawmakers passed HB 975 and SB 1008 in June 2024, mandating fingerprinting and criminal background checks for every physician renewing a state license. The new requirement treats doctors as potential criminals despite a national conviction rate of only about 0.3 percent for...
Why the New NHS Financial Year Must Fund Stability Today and Digital Maturity for Tomorrow
The NHS’s 2026/27 budget must adopt a dual‑track strategy that safeguards core clinical services while ring‑fencing funds for digital transformation. Richard Oswald of Exponential‑e argues that electronic records, interoperable platforms and secure infrastructure are no longer optional but essential for...
From Reactive to Proactive: Building the Digital Front Door for the NHS
In a video interview, Mark Ratnarajah, a paediatrician and UK Managing Director at Sword Intelligence, outlines how Agentic AI is being deployed as a digital front door for the NHS. The technology promises a 74% cut in delivery costs and...
From Fringe to Formulary: How Integrative Medicine, Peptides, and the D2C Biomarker Stack Are Reshaping the Boundaries of Evidence-Based Care
Integrative health, once a fringe market, now commands a $30 billion out‑of‑pocket industry with 37 % of U.S. adults spending on modalities like acupuncture, functional‑medicine and peptide protocols. Federal agencies are building measurement tools—NIH’s NCCIH $170 M Whole Person Health Index—and the VA’s...
Ultra-Processed Foods May Raise Risk of Preterm Birth and Pregnancy Complications, Study Finds
A large U.S. study of 6,693 pregnancies found that each 10‑percentage‑point rise in calories from ultra‑processed foods (UPFs) during pregnancy is associated with an 11% higher risk of preterm birth and a 5% increase in hypertensive disorders such as preeclampsia....
Guideways Launches AI Platform to Get Life-Changing Medical Devices to Patients Faster
Guideways has launched an agentic AI platform designed to streamline FDA approval for medical devices. The system deploys three specialized AI agents—FDA Sherpa, FDA Reviewer, and FDA Researcher—to guide teams from concept through submission, leveraging a curated knowledge base of...
When Surgeons Say ‘Wow’: A Game Changer for Orthopaedic Surgery
The SWASH+ NHS consortium has rolled out Sectra’s 3‑D orthopaedic planning software across five trusts, letting surgeons virtually reconstruct fractures before entering the operating theatre. The tool slashes multidisciplinary team (MDT) preparation time by up to 50% and accelerates pre‑operative...
Redefining Physician Leadership and Adversity After a Life-Changing Illness
Dr. Bertina Marie Hooks, an internal‑medicine physician, recounts how a right below‑knee amputation forced her to confront a shattered professional identity. The physical recovery revealed that true leadership extends beyond competence, demanding self‑reconstruction amid ongoing clinical responsibilities. She argues that...
High Dose Influenza Vaccine Correlates with Greater Reduction in Dementia Risk
A retrospective cohort study of U.S. seniors found that receiving a high‑dose inactivated influenza vaccine (H‑IIV) was associated with a significantly lower risk of Alzheimer’s disease compared with the standard‑dose vaccine (S‑IIV). The analysis used claims data from 2014‑2019, covering...
Ready to Rethink the Bias Embedded in Prevention?
A new paper in *Current Obesity Reports* challenges the entrenched bias that frames obesity prevention as a matter of personal responsibility. It argues that decades of investment in “eat less, move more” campaigns have failed because they ignore the complex...
How Does the Complexity of Obesity Impact the Effectiveness of GLP-1s?
The FDA granted accelerated approval for a high‑dose injectable version of Wegovy, while Novo Nordisk introduced a multi‑month subscription model aimed at telehealth prescribers. New data from Phenomix and the Mayo Clinic reveal that many patients lack a clear understanding...
How to Make Cancer Therapies BETter: An Insight Into the Distinct Roles of BET Proteins
A new study from the Max Planck Institute reveals that BET proteins BRD2 and BRD4 play distinct, sequential roles in gene activation, explaining why broad‑spectrum BET inhibitors have shown limited clinical success. BRD4 drives the release of RNA polymerase II,...
Breathing New Life Into Tubercolosis Treatment with Iinhalable Nanomedicine
Scientists at the University of Witwatersrand’s Wits Advanced Drug Delivery Platform have created an inhalable nanocarrier that can encapsulate all four first‑line tuberculosis drugs and release them directly in the lungs. The system bypasses the liver and bloodstream, aiming to...
Octopus-Shaped Nanomachine Reprograms ATP Flow to Starve Cancer Cells
Researchers unveiled an octopus‑shaped nanomachine, HSA‑ABC, that anchors to cancer cell membranes and uses an ATP‑sensing aptamer to trigger photodynamic therapy and rapid doxorubicin delivery. The device creates a self‑amplifying cycle: ATP binding activates a photosensitizer, damaging the membrane, which...
“I Don’t Need Those Pills”—Until the Second Heart Attack
At ACC 2026, researchers unveiled the Ez‑PAVE trial, a multicenter, randomized study of 3,048 South Korean patients with established atherosclerotic cardiovascular disease. The trial compared an ultra‑low LDL‑C target of <40 mg/dL against a conventional target of <70 mg/dL, using statin plus...